Latest News

The Dominican Republic production shift at AJR is still waiting on customer qualification, so its cost-benefit has not yet reached the margins.

All 15 of the top 15 AI leaders use Datadog's tools, and its non-AI business is also accelerating.

Both of these defensive stocks are growing sales about 6%, but one offers a higher yield and a lower valuation as cocoa costs weigh on its shares.

This low-cost index fund could deliver millionaire-making returns.

Uber is pausing big deals to integrate recent ones, so its capital will go to organic growth and buybacks instead of acquisitions.

U.S. pricing pressure weighs on Novo Nordisk's growth, but management is counting on the pipeline to offset it over the long haul.

Evolus (NASDAQ:EOLS) reported third-quarter revenue of $78 million, up 13% from a year earlier, as sales of its injectable products grew and the company posted its fourth consecutive quarter of positive adjusted EBITDA. The aesthetics company reaffirmed its 2026 revenue forecast and lowered its out

Fastly (NASDAQ:FSLY) reported record third-quarter revenue of $190.2 million and raised its full-year outlook, as increased traffic from large customers and security product sales helped drive a fourth consecutive quarter of revenue growth of at least 20%. Revenue rose 20% from a year earlier and e

Dave (NASDAQ:DAVE) raised its full-year revenue and profit outlook after third-quarter revenue rose 31% from a year earlier, supported by record member additions, higher revenue per user and increased ExtraCash originations. The financial technology company reported revenue of $198 million for the

Encore Capital Group (NASDAQ:ECPG) reported record collections and higher third-quarter earnings, as the debt buyer increased its full-year collections outlook and projected continued earnings growth in 2027. Global collections rose 14% from a year earlier to $754 million, while net income increase

8X8 (NASDAQ:EGHT) raised its fiscal 2027 revenue, earnings and operating cash flow outlook after reporting a sixth consecutive quarter of year-over-year revenue growth, driven in part by demand for usage-based communications services. For the fiscal second quarter ended in September, total revenue

Cytokinetics (NASDAQ:CYTK) reported $44.5 million in third-quarter net revenue from heart drug MYQORZO, up 76% from the prior quarter, as the company prepares regulatory submissions that could expand the treatment’s use. President and CEO Robert Blum said the launch, nearly nine months in, continue

Allegiant Travel (NASDAQ:ALGT) reported a narrower operating margin improvement and a slight adjusted loss for the third quarter of 2026, as strong leisure demand and higher fares helped offset a sharp increase in fuel costs. The airline maintained its forecast for full-year adjusted earnings of mo

Chime Financial (NASDAQ:CHYM) reported accelerating revenue growth and its third consecutive quarter of GAAP net income in the third quarter of 2026, as its Prime membership tier and lending products helped lift revenue per active member. Revenue rose 32% from a year earlier to $718 million, compar

Freshpet's marketing bet is tilted toward its most valuable households, which the article says make up 72% of sales, so the company is protecting that base.

A single confirmatory Phase III trial design could streamline the path to regulatory approval if November data validates the oligomer-targeting approach.

Retailer restocking after cyberattacks turned temporary outages into a sales boost, while closing a factory targets overhead rather than shelf prices.

TikTok Shops in 14 countries now feed sales into major retailers and direct-to-consumer sites, reaching beyond traditional channels.

Large deal wins provide multiyear revenue visibility even as near-term pricing pressure forces guidance cuts.

Intuit took steps to embrace AI.

The bank's willingness to sacrifice market share for loan pricing power signals how disciplined management can sustain profitability across rate cycles.

Brookfield Infrastructure's growing cash earnings support its payout, with financing costs setting the pace of the next increase.

A rival chipmaker is buying a big laser maker. Is the AI chip giant's stock, around 30% under its record, still worth buying?

Gross margin climbed to 22.5% in the first half, and management expects further gains, pointing to better profit quality beyond sheer deal volume.

Investors were clearly impressed by the gaming company's third-quarter performance.